23
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Serial Changes in the Galactosylation of Autoantibodies and Serum IgG in Autoimmune Haemolytic Anaemia

, &
Pages 103-108 | Received 01 Oct 1998, Accepted 27 Apr 1999, Published online: 07 Jul 2009

References

  • Thompson S. J., Leader K. A., Lastra G. C., Elson C. J. The role of agalactosyl IgG in rodent models of autoimmune disease and in the pathogenesis of rheumatoid arthritis. Abnormalities of IgG Gloeosylalion and Immunological Disorders, S. A. lsenberg, T. W. Rademacher. John Wiley & Sons Ltd. 1996; 131–148
  • Hadley A. G., Zupanska B., Kumpel B. M., Pilkington C., Griffiths H. L., Leader K. A., Jones, Booker D. J., Stamps R., Sokol R. J. The glycosylation of red cell autoantibodies and their functional activity in vivo. Br. J. Haematol 1995; 91: 587–594
  • Lastra G. C., Thompson S. J., Lemonidis A. S., Elson C. J. Changes in the galactose content of IgG during humoral immune responses. Autoimmunity 1998; 28: 25–30
  • Barker R. N., Young R. D., Leader K. A., Elson C. J. Galactosylation of serum IgG and autoantibodies in murine models of autoimmune haemolytic anaemia. Clin. Exp. Immunol 1999; 117: 449–454
  • Rumpel B. M., Wang Y., Griffiths H. L., Hadley A. G., Rook G. A.W. The biological activity of human monoclonal IgG antiD is reduced by beta-galactosidase treatment. Human Antibodies and Hybridomas 1995; 6: 82–88

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.